CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

LA JOLLA, Calif., Sept. 3, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a presentation at the H.C. Wainwright 26^th Annual Global Investment Conference on Monday, September 9, 2024, at 7:00 a.m. ET/ 4:00 a.m. PT.

Read more at prnewswire.com